# US 2026/0074070 A1 · Virtual procedure modeling, risk assessment and presentation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0074070 A1
- Document ID: US20260074070A1
- Status: Published application
- Kind: A1
- Application number: 19/104,935
- Filed: 2023-06-06
- Published: 2026-03-12
- Earliest claimed: 2022-09-15
- Assignees: Medtronic Vascular, Inc.
- Applicants: Medtronic Vascular, Inc.
- Inventors: James Delahunty; Brian J. Kelly; Jeffrey M. Zalewski
- Web page: https://patentgrep.com/patent/US20260074070A1

## CPC

- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H 20/40: relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
- G16H 30/40: for processing medical images, e.g. editing
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Example systems and techniques are disclosed that may determine at least one treatment strategy for a lesion. An example system may include memory configured to store a plurality of treatment pathways and processing circuitry communicatively coupled to the memory. The processing circuitry may be configured to determine the plurality of treatment pathways. The processing circuitry may be configured to determine, for each respective treatment pathway of the plurality of treatment pathways, one or more respective predicted effectiveness indicators, one or more respective predicted risks, and a respective confidence level associated with at least one of the respective predictions. The processing circuitry may be configured to output for display the plurality of treatment pathways, and the one or more respective predicted effectiveness indicators, the one or more respective predicted risks, and the respective confidence level associated with at least one of the respective predictions for each respective treatment pathway.

## Claims

### Claim 1

A medical system comprising:
memory configured to store a plurality of treatment pathways; and
processing circuitry communicatively coupled to the memory, the processing circuitry being configured to:
determine the plurality of treatment pathways;
determine, for each respective treatment pathway of the plurality of treatment pathways, one or more respective predicted effectiveness indicators associated with the respective treatment pathway, one or more respective predicted risks associated with the respective treatment pathway, and a respective confidence level associated with at least one of the respective predictions; and
output for display the plurality of treatment pathways, the one or more respective predicted effectiveness indicators associated with the respective treatment pathway, the one or more respective predicted risks associated with the respective treatment pathway, and the respective confidence level associated with at least one of the respective predictions for each respective treatment pathway of the plurality of treatment pathways.

### Claim 2 (depends on 1)

The medical system of claim 1, wherein the processing circuitry is further configured to:
determine a recommended treatment pathway of the plurality of treatment pathways; and
output for display an indication of the recommended treatment pathway.

### Claim 3 (depends on 1)

The medical system of claim 1, wherein as part of determining the one or more respective predicted effectiveness indicators associated with the respective treatment pathway, the one or more respective predicted risks associated with the respective treatment pathway, and the respective confidence level associated with at least one of the respective predictions, the processing circuitry is configured to execute a machine learning algorithm.

### Claim 4 (depends on 3)

The medical system of claim 3, wherein as part of determining the one or more respective predicted effectiveness indicators associated with the respective treatment pathway, the one or more respective predicted risks associated with the respective treatment pathway, and the respective confidence level associated with at least one of the respective predictions, the processing circuitry is configured to:
generate a three-dimensional (3D) model of vasculature of a patient; and
execute the machine learning algorithm, using input derived from the 3D model of the vasculature of the patient.

### Claim 5 (depends on 1)

The medical system of claim 1, wherein as part of determining the one or more respective predicted effectiveness indicators associated with the respective treatment pathway, the one or more respective predicted risks associated with the respective treatment pathway, and the respective confidence level associated with at least one of the respective predictions, the processing circuitry is configured to run a plurality of simulations.

### Claim 6 (depends on 1)

The medical system of claim 1, wherein the processing circuitry is configured to determine the one or more respective predicted effectiveness indicators associated with the respective treatment pathway based on a device performance prediction.

### Claim 7 (depends on 1)

The medical system of claim 1, wherein the one or more respective predicted effectiveness indicators associated with the respective treatment pathway comprises at least one of a respective predicted fractional flow reserve (FFR) value, a respective predicted quality of life improvement, or at least one respective predicted readmission rate.

### Claim 8 (depends on 1)

The medical system of claim 1, wherein each of the plurality of treatment pathways further comprises at least one of a respective inventory availability or cost.

### Claim 9 (depends on 1)

The medical system of claim 1, wherein, in response to clinician input of a selected one of the plurality of treatment pathways, the processing circuitry is configured to:
determine a plurality of treatment options of the selected treatment pathway, each of the plurality of treatment options comprising one or more respective predicted effectiveness indicators associated with the respective treatment option, one or more respective predicted risks associated with the respective treatment option, a respective confidence level associated with at least one of the respective predictions for the respective treatment option, and suggested device parameters for the respective treatment option; and
output for display the plurality of treatment options of the selected treatment pathway, and the one or more respective predicted effectiveness indicators associated with the respective treatment option, the one or more respective predicted risks associated with the respective treatment option, the respective confidence level associated with at least one of the respective predictions for the respective treatment option, and the suggested device parameters for the respective treatment option.

### Claim 10 (depends on 9)

The medical system of claim 9, wherein the processing circuitry is further configured to:
during a percutaneous coronary intervention (PCI) procedure, determine a live reading, the live reading comprising one or more live predicted effectiveness indicators associated with the PCI procedure, one or more live risks associated with the PCI procedure, a live confidence level associated with at least one of the respective predictions for the PCI procedure, and live suggested device parameters for the PCI procedure; and
output for display one of the plurality of treatment options and the live reading.

### Claim 11 (depends on 1)

The medical system of claim 1, wherein the processing circuitry is further configured to:
determine at least one of a ghosted preview of a PCI procedure, a graphical predicted FFR, a graphical predicted risk of rupture, or a graphical predicted probability of a successful outcome; and
output for display, during the PCI procedure, at least one of the ghosted preview of the procedure, the graphical predicted FFR, the graphical predicted risk of rupture, or the graphical predicted probability of a successful outcome.

### Claim 12

A method comprising:
determining a plurality of treatment pathways;
determining, for each respective treatment pathway of the plurality of treatment pathways, one or more respective predicted effectiveness indicators associated with the respective treatment pathway, one or more respective predicted risks associated with the respective treatment pathway, and a respective confidence level associated with at least one of the respective predictions; and
outputting for display the plurality of treatment pathways, and the one or more respective predicted effectiveness indicators associated with the respective treatment pathway, the one or more respective predicted risks associated with the respective treatment pathway, and the respective confidence level associated with at least one of the respective predictions for each respective treatment pathway of the plurality of treatment pathways.

### Claim 13 (depends on 12)

The method of claim 12, further comprising:
determining a recommended treatment pathway of the plurality of treatment pathways; and
outputting for display an indication of the recommended treatment pathway.

### Claim 14 (depends on 12)

The method of claim 12, wherein determining the one or more respective predicted effectiveness indicators associated with the respective treatment pathway, the one or more respective predicted risks associated with the respective treatment pathway, and the respective confidence level associated with at least one of the respective predictions comprises executing a machine learning algorithm.

### Claim 15

A non-transitory computer-readable storage medium storing instructions, which, when executed, cause processing circuitry to:
determine a plurality of treatment pathways;
determine, for each respective treatment pathway of the plurality of treatment pathways, one or more respective predicted effectiveness indicators associated with the respective treatment pathway, one or more respective predicted risks associated with the respective treatment pathway, and a respective confidence level associated with at least one of the respective predictions; and
output for display the plurality of treatment pathways, the one or more respective predicted effectiveness indicators associated with the respective treatment pathway, the one or more respective predicted risks associated with the respective treatment pathway, and the respective confidence level associated with at least one of the respective predictions for each respective treatment pathway of the plurality of treatment pathways.

### Claim 16 (depends on 14)

The method of claim 14, wherein determining the one or more respective predicted effectiveness indicators associated with the respective treatment pathway, the one or more respective predicted risks associated with the respective treatment pathway, and the respective confidence level associated with at least one of the respective predictions, comprises:
generating a 3D model of vasculature of a patient; and
executing the machine learning algorithm, using input derived from the 3D model of the vasculature of the patient.

### Claim 17 (depends on 12)

The method of claim 12, wherein determining the one or more respective predicted effectiveness indicators associated with the respective treatment pathway, the one or more respective predicted risks associated with the respective treatment pathway, and the respective confidence level associated with at least one of the respective predictions comprises running a plurality of simulations.

### Claim 18 (depends on 12)

The method of claim 12, wherein determining the one or more respective predicted effectiveness indicators associated with the respective treatment pathway is based on a device performance prediction.

### Claim 19 (depends on 12)

The method of claim 12, wherein the one or more respective predicted effectiveness indicators associated with the respective treatment pathway comprises at least one of a respective predicted fractional flow reserve (FFR) value, a respective predicted quality of life improvement, or at least one respective predicted readmission rate.

### Claim 20 (depends on 12)

The method of claim 12, wherein each of the plurality of treatment pathways further comprises at least one of a respective inventory availability or cost.
